Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Amedisys Inc
(NQ:
AMED
)
97.49
+0.75 (+0.78%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
319,512
Open
97.00
Bid (Size)
92.55 (1)
Ask (Size)
97.59 (1)
Prev. Close
96.74
Today's Range
97.00 - 97.87
52wk Range
89.55 - 98.95
Shares Outstanding
32,631,959
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Contessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model
August 21, 2024
Guiding an Improved Dementia Experience (GUIDE) Model Aims to Increase Care Coordination, Support for Caregivers
From
Amedisys, Inc.
Via
GlobeNewswire
AMED Stock Earnings: Amedisys Beats EPS, Beats Revenue for Q2 2024
July 24, 2024
AMED stock results show that Amedisys beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
+2.65%
+2.65%
1 Month
+0.29%
+0.29%
3 Month
+0.04%
+0.04%
6 Month
+6.85%
+6.85%
1 Year
+5.12%
+5.12%
More News
Read More
AMED Stock Earnings: Amedisys Beats EPS, Beats Revenue for Q1 2024
April 24, 2024
Via
InvestorPlace
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes
April 23, 2024
Via
InvestorPlace
Is NASDAQ:AMED suited for quality investing?
August 14, 2023
Via
Chartmill
What 11 Analyst Ratings Have To Say About Amedisys
July 27, 2023
Via
Benzinga
Analyst Ratings for Amedisys
June 27, 2023
Via
Benzinga
3 Stocks To Turn $1,000 Into $10,000 in 10 Years
January 12, 2024
Via
InvestorPlace
3 Stocks Profiting from America’s Long-Term Care Crisis
November 22, 2023
Via
InvestorPlace
Cantor Fitzgerald Maintains Neutral Rating for Amedisys: Here's What You Need To Know
September 14, 2023
Via
Benzinga
The 3 Best Stock Picks for This Week
September 05, 2023
Via
InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EchoStar Corporation (Nasdaq - SATS), Sovos Brands, Inc. (Nasdaq - SOVO), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Amedisys, Inc. (Nasdaq – AMED)
August 08, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Expert Ratings for Amedisys
June 06, 2023
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reata Pharmaceuticals, Inc. (Nasdaq – RETA), Talaris Therapeutics, Inc. (Nasdaq – TALS), Inpixon® (Nasdaq – INPX), Amedisys, Inc. (Nasdaq – AMED)
July 28, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)
July 25, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)
July 20, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Is UnitedHealth Group Stock a Buy Now?
July 11, 2023
Via
The Motley Fool
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq – AMED)
July 10, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023
July 06, 2023
Via
Benzinga
Meta Platforms To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday
July 06, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2023
June 28, 2023
Via
Benzinga
AMED Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amedisys, Inc. Is Fair to Shareholders
June 26, 2023
From
Halper Sadeh LLC
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
June 07, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2023
June 06, 2023
Via
Benzinga
Optum's Decision To Target Amedisys Is Intriguing, Says Analyst
June 05, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.